Cancer Research (Assistant/Associate)

Rutgers Cancer Institute invites applications for faculty positions in cancer research for tenure track and non-tenure track positions. New tenure track faculty are expected to establish or support an innovative, independent and collaborative research program addressing important, fundamental questions in the area of cancer biology. Interdisciplinary and translational approaches are encouraged that establish collaborations with consortium faculty. Candidates with a demonstrated ability to secure peer reviewed funding are preferred. We are also seeking applications from candidates with interests in precision medicine and phase 1 development. Faculty will have the exciting opportunity to be involved in teaching activities for medical students and residents as well as targeted lectures in their area of expertise.

Rutgers Cancer Institute is an NCI-designated, comprehensive and consortium cancer center that includes faculty members from across Rutgers University (including Rutgers Robert Wood Medical School, Rutgers Biomedical and Health Sciences) and Princeton University. We are a leader in basic, clinical, prevention, and public health science, offering world-class quality cancer care providing the most advanced medicines and treatment options for patients in our health system network across the state . Visit our website at www.cinj.org .

Preferred research areas include:
Genomic Instability and Cancer Genetics- Open rank, tenure track faculty position with a basic, translational, or preclinical research focus in cancer genetics and genomics, including therapeutic vulnerabilities of dysregulated DNA repair and altered cancer genomes, strategies and mechanisms of radiation therapy at cellular and molecular levels, the co-adaption between tumor environment and the evolving cancer cells, and genetics of cancer predisposition syndromes.

Cancer Pharmacology- Open rank, tenure track faculty position with a research focus in cancer pharmacology, including structure-guided drug discovery and development, the biology of key molecular targets of cancer, and mechanisms of action and resistance of cancer therapies. We are especially interested in individuals with strong background in translation of basic science to patient care or drug discovery applying DNA-encoded library screening, PROTAC and other innovative small molecule drug discovery technologies, or therapeutic antibody engineering and development.

Tumor Immunology- Open rank, tenure track faculty position with a research focus in tumor immunology including cancer immunotherapy, immunometabolism, CAR-T therapy, checkpoint blockade, T cell biology, tumor antigens, tumor immune evasion, and viral and non-viral gene transfer and gene editing. The successful candidate will join a team of researchers and clinicians of the newly established Cancer Immunology and Metabolism Center of Excellence, a $30 million initiative co-directed by Drs. Christian Hinrichs and Eileen White. For details and to apply: http://jobs.rutgers.edu/postings/120926

Pediatric Cancer- Open rank, tenure track faculty position with research related to pediatric cancer or blood disorder, with interests in stem cell biology and transplantation; cellular therapies; immunotherapeutics; cancer predisposition syndromes; or gene therapies. Successful recruits will be aligned with one of the basic research programs of Tumor Immunology, Genomic Instability and Cancer Genetics, or Cancer Pharmacology. For details and to apply: https://jobs.rutgers.edu/postings/210813

For questions on this position or to learn more about our available positions , please contact the Rutgers Cancer Institute Faculty Recruitment Office at cinjcareers@rutgers.edu.

See all our open faculty positions here!

Qualified candidates must have a PhD and/or MD, outstanding academic credentials, and a history or strong potential for grant funding. Rank will be commensurate with experience.

New Jersey's premier academic health center, Rutgers Biomedical and Health Sciences ( RBHS) takes an integrated approach to educating students, providing clinical care, and conducting research, all with the goal of improving human health. Aligned with Rutgers University-New Brunswick and collaborating university wide, RBHS includes eight schools, a behavioral health network, and five centers and institutes that focus on cancer treatment and research, neuroscience, advanced biotechnology and medicine, environmental and occupational health, and health care policy and aging research. Our renowned faculty are teachers, health researchers and providers, and scientists with unparalleled experience who advance medical innovation and provide patient care informed by the latest research findings. We offer an outstanding education and training in medicine, dentistry, pharmacy, public health, nursing, biomedical research, and the full spectrum of allied health careers. An important mission of RBHS is to promote the careers of faculty, staff, and learners. Through this community of healers, scientists, and scholars, Rutgers is equipped as never before to transform lives.

Rutgers Robert Wood Johnson Medical School
As one of the nation's comprehensive medical schools, Rutgers Robert Wood Johnson Medical School ( RWJMS) is dedicated to pursuing excellence in education, research, healthcare delivery, and the promotion of community health. In cooperation with Robert Wood Johnson University Hospital, the medical school's principal affiliate, they comprise New Jersey's premier academic medical center. In addition, RWJMS has 34 other hospital affiliates and ambulatory care sites throughout the region. RWJMS encompasses 20 basic science and clinical departments and hosts centers and institutes, described below. The medical school maintains undergraduate, graduate, and postgraduate educational programs for more than 1,500 students on its campuses in New Brunswick and Piscataway. It provides continuing education courses for healthcare professionals and community education programs. Previously an academic unit of the University of Medicine and Dentistry of New Jersey, RWJMS became part of Rutgers, The State University of New Jersey, as part of the New Jersey Medical and Health Sciences Education Restructuring Act, on July 1, 2013.

As New Jersey's only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey, in partnership with RWJBarnabas Health, is a leader in cancer research, treatment, prevention, and education. Rutgers Cancer Institute offers world-class cancer care, providing patients with the most advanced treatment options through an integrated cancer care network, including clinical trials, immunotherapy, precision medicine, complex surgical procedures, and sophisticated radiation therapy techniques. Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, are one of only two programs in the state to offer blood and marrow transplantations and CAR T-cell therapy. It also houses the state's only hospital-based proton therapy center. Rutgers Cancer Institute is a cornerstone of New Jersey's premier academic health center, Rutgers Biomedical and Health Sciences ( RBHS).

Construction is currently underway for a new $750 million state-of-the-art Cancer Center adjacent to the current Rutgers Cancer Institute facility and Robert Wood Johnson University Hospital. The 510,000 square foot Jack and Sheryl Morris Cancer Center will be the state's first free-standing cancer hospital. It will feature outpatient and inpatient clinical space-including 84 infusion bays, 74 exam rooms, and 96 inpatient beds. This is in addition to state-of-the-art laboratories where critical scientific investigation will be amplified, enabling physician-scientists to translate findings directly to patients. The Jack and Sheryl Morris Cancer Center will also have the capacity to offer wellness and education resources all in one location. Learn more about this incredible facility at www.cinj.org/jackandsherylmorriscancercenter .

Rutgers Cancer Institute is home to nearly 250 internationally recognized physicians and researchers. The long-standing relationship with their NCI Research Consortium Partner Princeton University was recently leveraged to establish the Ludwig Cancer Research Princeton Branch with several faculty as founding members and leaders of the Branch. Their work on cancer metabolism, not only through the new Ludwig Branch but also through the Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence at Rutgers Cancer Institute, will accelerate and translate laboratory discoveries into clinical treatments through more effective and efficiently designed clinical trials.

The Rutgers Cancer Institute's Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence is an institute at the intersection of oncologic immunology and metabolism that seeks to increase research that leads to new therapies for patients; develop cutting-edge facilities to test new interventions; and facilitate commercial and university collaborations. This includes discovery and production of novel cell therapy constructs via an institutional good manufactory practices ( GMP) facility. Visit Center of Excellence in Cancer Immunology and Metabolism .

Rutgers Cancer Institute is committed to retaining, recruiting, and developing outstanding faculty, staff, and students, including those traditionally underrepresented in medicine in faculty, staff, and student bodies. It aspires to be an agent of progress in advancing equality and justice while improving healthcare access and reducing healthcare disparities. Visit us here. More information on our community here.

Rutgers Cancer Institute, the state's only NCI-designated Comprehensive Cancer Center and RWJBarnabas Health, the state's largest health care delivery system partner to deliver high-quality and sophisticated oncology care to patients close to home. This integrated cancer care model combines the strength of both entities, offering access to the most advanced diagnostic and treatment options for adult and pediatric cancer patients, including clinical trials, immunotherapy, proton therapy, precision medicine, CAR T-cell therapy and cardio-oncology. Through the above mentioned partnership and an academic appointment at Rutgers, The State University of New Jersey, unique opportunities exist for collaborations between clinical and research programs, including clinical trials research, cancer chemoprevention, clinical and basic pharmacology, and Phase 1 clinical trials.

Mission
To accelerate scientific discovery focused on understanding cancer, innovating cancer treatment, and improving cancer prevention; to provide outstanding, novel, and compassionate patient care; to provide evidence-based and culturally informed education to physicians, nurses, researchers, staff, and the community; and to achieve cancer health equity in our state through outreach to and engagement of our extraordinarily diverse communities

Vision
Through our science, our evidence-based actions, our openness, and our respect for those we serve, we will advance cancer-focused research worldwide and reduce the burden of cancer in our catchment area. By engaging with and empowering our exceptionally diverse populations, and addressing their questions and fears, we will engender hope for cancer patients and their families and play a critical role in strengthening the fabric of our communities by gaining and protecting their trust and providing access to the outstanding oncology care each person deserves.

Core Values
* Curiosity and Discovery : encouraging an environment of continuous inquiry, creativity, and innovation to generate new knowledge
* Integrity : earning the trust of those we serve and each other through honesty, transparency, accountability, and continuous reflection
* Collaboration: approaching all opportunities with an understanding that together we are better and can achieve more; promoting and maintaining an environment of teamwork and shared knowledge
* Cultivating Diversity: making conscientious efforts in all we do to ensure that our leadership, scientists, clinicians, supporting staff, and trainees reflect the rich diversity of the state of New Jersey and the patient populations and communities we serve
* Respect and Caring : consistently demonstrating caring, compassion, and respect through our words and actions
* Perseverance : maintaining an unwavering commitment to our mission; embracing change, overcoming obstacles, and creating and recreating the path to achieve our goals

Rutgers Cancer Institute Commitment to Diversity, Equity, and Inclusion

It is our responsibility to every participant in the healthcare space to address the longstanding, systemic structures of racism that affect our faculty and staff from thriving in the advancement of science and patient care. We understand that our patients, faculty, and staff come from all over and carry unique cultures and norms that impact how they interpret the world, their experiences, and their relationships. We are committed to fostering a diverse and inclusive environment where people who seek cancer care and the workforce that provide cancer care, both directly and indirectly, feel represented, welcomed, included, and supported.

Applicants should submit a CV, a research statement, a cover letter detailing how the candidate's work will contribute to the Rutgers Cancer Institute Mission, and list 3 references with contact information or upload reference letters. Please contact cinjcareers@cinj.rutgers.edu with any questions about the application process.